TrialThe Lancet. Respiratory medicine2021

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

François-Xavier Lescure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.